Sponsor Pipeline

Jiangmen Central Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07482605 Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion Lung Cancer (NSCLC) Not Yet Recruiting
NCT07583550 Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy, and Then… Lung Not Yet Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when Jiangmen Central Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free